Artiva Biotherapeutics (ARTV) Return on Equity (2024 - 2026)

Artiva Biotherapeutics (ARTV) has 3 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, up 5.0% from the prior year.
• Return on Equity declined to 0.01% in Q1 2026 per ARTV's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Equity peaked at 0.0% in Q2 2024 and troughed at 0.07% in Q3 2024.
• A 3-year average of 0.01% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 6 bps in 2025 and fell as far as 0 bps in 2025.
• A 3-year view of Return on Equity shows it stood at 0.0% in 2024, then sank by 119 bps to 0.01% in 2025, then retreated by 26 bps to 0.01% in 2026.
• Business Quant data shows ARTV's Return on Equity at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.